Plant NLR mediated immunity: Cell Press
Plant NLR mediated immunity
Related Articles
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer | NEJM
Imlunestrant is a next-generation, brain-penetrant, oral selective estrogen-receptor (ER) degrader that delivers continuous ER inhibition, even in cancers with mutations in the gene encoding ERα…
AI versus AI: The emerging arms race over health insurance denials
As health insurers use AI to deny more claims, startups are turning to AI to make it easier to appeal denials, which often go uncontested.
Exploring symptoms perception and barriers to medication adherence among Thai Muslim patients with non-communicable diseases in a rural community in southern Thailand: a mixed-methods study
Objectives This study aimed to explore the prevalence of medication non-adherence and influence of symptom perception and various barriers on medication adherence among Thai Muslim…
Syria: Doctors warn of refeeding syndrome and infections in released prisoners
Doctors from Syria who work for the NHS have told The BMJ about “Holocaust-like” scenes that have unfolded at the liberated Saydnaya military prison 18…
The nucleoporin Nup153 is the anchor for Kif1a during basal nuclear migration in brain progenitor cells
Falnikar et al. report that the nucleoporin Nup153, a binding partner of microtubule motor protein Kif1a, originally identified in a proteomic study, recruits Kif1a to the…
Efficacy of melatonin for prolonged disorders of consciousness: a double-blind, randomized clinical trial – BMC Medicine
Background Sleep is essential for the recovery of patients with disorders of consciousness (DoC). However, few approaches targeting sleep were applied. Melatonin has been shown…
‘Ghost networks’ lawsuit may signal trouble for insurers
A law firm alleging Anthem deliberately includes out-of-network providers in its directories is eyeing UnitedHealthcare, Aetna and other insurers.
Journalists: please don’t make yourself part of a health news story
Your story may hold no relevance for anyone else and may come off more like marketing than journalism
Drug Reaction with Eosinophilia and Systemic Symptoms | NEJM
This review focuses on DRESS, a serious drug-induced T-cell–mediated condition with marked cutaneous and systemic effects.
Why Stoke Therapeutics’ Dravet syndrome drug is worth watching
Stoke Therapeutics is nearing FDA sign-off on a groundbreaking Phase 3 clinical trial for its experimental drug for Dravet syndrome.
